Bright Health Group Inc.

NYSE: BHG · Real-Time Price · USD
16.35
1.40 (9.36%)
At close: Jan 26, 2024, 10:00 PM

Bright Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
751.12M 828.2M 1.02B 1.09B 1.62B 1.88B 3.24B 4.52B 5.6B 6.01B 5.45B 4.99B 4.03B 3.43B 2.7B 1.88B
Cost of Revenue
595.8M 765.21M 1.05B 1.05B 1.49B 1.68B 2.91B 4.06B 4.95B 7.04B 6.63B 6.14B 5.24B 3.01B 2.27B 1.6B
Gross Profit
155.32M 62.99M -30.21M 36.44M 126.17M 195.74M 328.21M 453.85M 641M -1.03B -1.18B -1.15B -1.22B 414.5M 427.59M 282.06M
Operating Income
384.35M 318.87M -590.87M -588.27M -631.4M -732.58M -405.72M -630.39M -724.99M -1.38B -1.54B -1.35B -1.2B -541.99M -304.96M -273.16M
Interest Income
-19.21M -19.21M 10.04M 19.21M 27M 33.38M 28.25M 19.08M 11.29M 4.91M n/a n/a n/a n/a n/a n/a
Pretax Income
413.06M 353.15M -606.59M -615.96M -670.04M -801.27M -576.18M -792.02M -875.88M -1.51B -1.54B -1.36B -1.2B -547.05M -309.65M -273.7M
Net Income
635.99M 418.53M -1.02B -1.06B -1.08B -1.03B -655.22M -793.72M -879.55M -1.5B -1.55B -1.34B -1.18B -534.18M -292.77M -266.32M
Selling & General & Admin
130.78M 130.78M 66.2M 130.78M 259.99M -80.58M 152.84M 382M 584.18M 1.28B 1.21B 1.1B 914.12M 685.02M 526.3M 403.98M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
1.13B 1.25B 1.58B 1.66B 1.41B 1.61B 890.83M 702.25M 781.81M 2.03B 2.02B 1.97B 1.93B 179.7M 206.25M 151.24M
Operating Expenses
1.26B 1.38B 951.69M 776.37M 663.04M 520.37M 732.65M 1.08B 1.37B 2.95B 2.96B 2.81B 2.59B 956.49M 732.56M 555.21M
Interest Expense
4.45M 9.01M 30.77M 34.53M 38.2M 33.38M 28.25M 19.41M 12.82M 8.11M 4.8M 8.6M 7.96M 6.28M 4.69M 546K
Selling & Marketing Expenses
-888K -888K 258K 888K 21.23M -145.89M -68.42M 10.88M 82.34M 353.58M 345.3M 329.36M 287.75M 241.52M 188.02M 138.51M
Cost & Expenses
1.85B 2.15B 2B 1.83B 2.15B 2.2B 3.64B 5.15B 6.32B 9.99B 9.6B 8.95B 7.83B 3.97B 3.01B 2.16B
Income Tax Expense
8M 9.48M 811K -2.87M -1.43M -7.25M -2.1M 1.7M 3.68M -389K -2.08M -24.45M -26.52M -18.22M -18.3M -8M
Shares Outstanding (Basic)
8.57M 8.23M 8.28M 8.25M 7.95M 7.98M 7.96M 7.89M 7.85M 7.87M 7.87M 7.86M 1.47M 7.88M 2.01M 1.75M
Shares Outstanding (Diluted)
8.57M 8.23M 8.28M 8.25M 7.95M 7.98M 7.96M 7.89M 7.85M 7.87M 7.87M 7.86M 999.36K 7.88M 2.01M 1.75M
EPS (Basic)
81.40 53.83 -127.1 -132.76 -136.12 -129.62 -83.1 -100.89 -111.86 -60.24 -65.45 -55.62 -47 -170.32 -166.93 -155.45
EPS (Diluted)
81.40 53.83 -127.1 -132.76 -136.12 -129.62 -83.1 -100.89 -111.86 -60.24 -65.45 -55.62 -47 -170.32 -166.93 -155.45
EBITDA
660.84M 449.9M -399.75M -356.98M -365.99M -294.07M -364.1M -582.97M -673.63M -1.33B -1.49B -1.31B -1.16B -512.04M -287.77M -261.07M
EBIT
128.8M 82.43M -95.82M -128.8M -226.95M -279.63M -482.88M -518.63M -530.88M -1.25B -1.29B -1.28B -1.2B -540.76M -304.96M -273.16M
Depreciation & Amortization
12.4M 12.87M 15.63M 18.26M 24.17M 30.55M 40.33M 47.43M 51.36M 50.46M 50.76M 44.73M 35.48M 28.72M 17.19M 12.08M